We are monitoring the impact of COVID-19 on Personalized Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10484
Share on
Share on

Global Personalized Medicine Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Therapeutic Area, End-user, Application and Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 10484
Pages: 190

Personalized Medicine Market Size (2021 to 2026)

According to our report, the global personalized medicine market size is forecasted to grow at 11.2% CAGR between 2020 to 2025 and worth USD 717 billion by 2026.

Personalized medicines understand an individual’s genes or proteins and then develop an approach to treat diseases. With personalized medicine, the researchers can quickly note the patient's molecular and clinical profiles. According to the GLOBAL survey in 2018, the number of cancer cases crossed 18.1 million worldwide. 

The same treatment procedures for the same disease may not work effectively for different people. Personalized medicine will reduce the wastage of time during trial-and-error methods for classical treatments as it entirely focuses on every individual's special characteristic. 

According to the Federal Drug Administration (FDA), personalized medicine mainly focuses on distinguishing patients who are most likely to get beneficial effects and the patients who incur side effects without gaining benefit. Therefore, personalized medicine plays a vital role in cancer treatment procedures. Unfortunately, according to the World Health Organization (WHO), around 1 in 6 are losing their lives due to cancer globally. Also, in 2018, there were approximately 9.6 million deaths due to cancer across the world. 

MARKET DRIVERS:

The rising prevalence of cancer patients to develop innovative treatment procedures is likely to propel the growth rate of the global personalized medicine market.

An increasing number of patients with cancer diseases are demanding to launch new treatment procedures with advanced technology, which is a significant factor for growing tremendously. Examining the functional effects of genes' different characteristics to develop new genetic technologies to cure cancer diseases solely fuel the market's demand. 

The increasing benefits of personalized medicine in gene therapy are enhancing the growth rate of the market.

In gene therapy, there are many advantages to personalized medicine to cure different targeted diseases. Therefore, this factor is significantly influencing the growth rate of the market. In addition, the rise in investments from government organizations in the medical sector is one factor leveling the market demand. 

Factors like ongoing R&D activities in healthcare with the government's support, raising awareness over the availability of different treatment procedures, and changes in food habits are fueling the growth rate of the personalized market. In addition, adopting sequencing technologies like Next Generation Sequencing (NGS) in genomics is evaluating the market demand. NGS delivers accurate data on the patient genetic, which helps the researchers develop personalized medicine. Growing advancements in the personalized diagnostics and increasing focus on companion diagnostics are lucrative to accelerate the market's demand. 

MARKET RESTRAINTS:

However, fewer reimbursement policies in undeveloped countries are slowly degrading the growth rate of the market. Also, less knowledge over the applications with personalized medicine is hindering the growth rate of the market. Furthermore, strict rules and regulations by government bodies to approve innovative products limit the personalized medicine market demand. Increasing competition between the market players is also impeding the growth rate of the market. In addition, the cost required to develop a personalized medicine is very high, which is quietly restraining the market demand. The difficulty in understanding the complex nature of drugs is another factor hindering the market's growth rate. 

COVID 19 Impact on Personalized Medicine Market:

COVID 19 pandemic has shown disrupted changes in every sector but no healthcare. Patients with chronic diseases like cancer and cardiovascular problems are at higher risk when infected with the coronavirus. Many of them across the world have lost their lives due to COVID 19. The patients with COVID 19 show various symptoms where personalized medicine is better to call for the clinical trials. Key players are in a race to find out a vaccine for the novel coronavirus disease. Six hundred nine trials were registered till 20 April 2020. As the coronavirus is spreading rapidly, there is a desperate need to find an effective vaccine. In these challenging times, personalized medicine studies play an essential role in yielding positive results. By 2021, it is estimated the market shares are growing significantly.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Therapeutic Area, End-User, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This report on the global personalized medicine market has been segmented and sub-segmented based on the therapeutic area, end-user, application, and region.

Personalized Medicine Market - By Therapeutic Area:

  • Oncology
  • Neurology
  • Cardiology
  • Antiviral
  • Psychiatry
  • Others

The oncology segment is gaining traction over market demand. The rise in cancer diseases due to changes in food habits and adopting a sedentary lifestyle is a significant factor for the segment to grow tremendously. Europe and the US are the major countries contributing the highest shares for this segment, increasing the patient pool in oncology for personalized medicine applications. Neurology and Cardiology are following the oncology segment are leading the dominant shares of the market. The rapid spread of COVID 19 is a crucial driving factor for these segments to grow. Government support through funds to improve the healthcare infrastructure is also leveraging the demand of the market.

Personalized Medicine Market - By End User:

  • Hospitals
  • Molecular Diagnostic Laboratories and Testing facilities
  • Academic Institutes, clinical care, and Research Laboratories
  • Contract Research Organizations
  • Bio and health informatics companies
  • Others (Service providers, partners, venture capitalists, etc.)

By end-user, the hospitals' segment is in the leading position of the market shares. An increase in the patient pool to hospitals with health disorders such as cancer, cardiovascular problems, and others is substantially lavishing the market's growth rate. Academic Institutes, clinical care, and Research Laboratories segment grow at the highest CAGR during the forecast period. Increasing investment in research centers by government bodies is accelerating the demand of the market.

Personalized Medicine Market – By Application:

  • Companion Diagnostics
  • Biomarker identification
  • Health Informatics
  • Clinical Research

Based on the Application, the companion diagnostics segment holds the highest shares of the market with IT's emergence in healthcare. Drug discovery is next in leading with the highest shares of the market. The rising demand to develop innovative drugs or vaccines favors the end-users solely to fuel the market demand. Biomarker identification

is also anticipated to have significant market shares due to ongoing research and development activities with sequencing technologies. Health informatics and clinical research are also deemed to have the highest growth opportunities in the coming years. Increasing awareness over the utilization of different laboratories and growing prevalence to launch new diagnostic procedures is likely to prompt these segments' demand. 

Personalized Medicine Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • Spain
    • France
    • Italy
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • The Middle East and Africa

Geographically, North America is dominating the global personalized medicine market with the largest shares and is expected to continue the same in foreseen years. Rising per capita income in developed and developing countries is surging the market's growth rate in this region. The U.S. is holding with the dominant shares of the market. The rising number of hospitals and increasing R & D activities are boosting the market's growth rate. Europe is positioned second in leading the prominent shares of the market with the rising disposable income and escalating expenditure on healthcare. According to Europa, governments invest hugely in personalized medicine, where USD 272.1 million were invested in 2018 in the UK. The Asia Pacific is anticipated to have the fastest growth rate during the forecast period. The increasing elderly population and rising demand for innovative technologies in various healthcare fields impact the market's growth rate towards positive.

KEY MARKET PLAYERS:

Some of the notable companies dominating the global personalized medicine market profiled in this report are GE Healthcare, Cepheid, Asuragen Incorporated, Illumina Inc., Abbot Incorporated, Dako A/S, Biogen, Genelex Corp, Exagen Diagnostics Inc., Qiagen Inc., DNA Direct, and Agendia N.V.

RECENT MARKET DEVELOPMENTS:

  • In May 2018, Advanced Diagnostic Laboratory Test (ADLT) received approval for FoundationOne CDx, and Foundation Medicine announced this. These are highly used for solid tumors that integrate with companion diagnostics. The company’s portfolio is expected to expand with this product approval. 
  • In October 2018, novel RNA-seq library preparation solutions were announced by Qiagen. It is expected that this solution will promote various applications in next-generation sequencing techniques. 
  • In January 2018, Foundation Medicine and the European Organization for Research and Treatment for Cancer were collaborated to promote Foundation’s comprehensive genomic profiling in personalized medicine. 
  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Therapeutic Area
      1. Oncology
      2. Neurology
      3. Cardiology
      4. Antiviral
      5. Psychiatry
      6. Others
      7. Y-o-Y Growth Analysis, By Therapeutic Area
      8. Market Attractiveness Analysis, By Therapeutic Area
      9. Market Share Analysis, By Therapeutic Area
    2. By End-users
      1. Hospitals
      2. Molecular Diagnostic Laboratories and Testing facilities
      3. Academic Institutes, clinical care, and Research Laboratories
      4. Contract Research Organizations
      5. Bio and health informatics companies
      6. Others (Service providers, partners, venture capitalists, etc.)
      7. Y-o-Y Growth Analysis, By End-User
      8. Market Attractiveness Analysis, By End-User
      9. Market Share Analysis, By End-User
    3. By Application
      1. Companion Diagnostics
      2. Biomarker identification
      3. Health Informatics
      4. Clinical Research
      5. Y-o-Y Growth Analysis, By Application
      6. Market Attractiveness Analysis, By Application
      7. Market Share Analysis, By Application
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. North America
      1. Introduction
      2. United States
      3. Canada
    3. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
      7. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. Africa
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. GE Healthcare
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Cepheid
    3. Asuragen Incorporated
    4. Illumina Inc.
    5. Abbot Incorporated
    6. Dako A/S
    7. Biogen
    8. Genelex Corp
    9. Exagen Diagnostics Inc.
    10. Qiagen Inc.
    11. DNA Direct
    12.  Agendia N.V.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
  13. List of Tables
  14. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of therapeutic area, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Personalized Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  3. Global Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  10. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  17. Global Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  18. Global Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  22. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  29. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  36. North America Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  38. North America Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  40. United States Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  41. United States Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  42. United States Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  43. Canada Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  44. Canada Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  45. Canada Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  46. Europe Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  47. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  48. Europe Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  49. Europe Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  50. Europe Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  51. Europe Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  52. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  53. Europe Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  54. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  56. Europe Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  60. Europe Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  61. Europe Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  62. Europe Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  64. Europe Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  65. U.K. Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  66. U.K. Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  67. U.K. Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  68. Germany Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  69. Germany Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  70. Germany Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  71. France Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  72. France Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  73. France Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  74. Italy Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  75. Italy Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  76. Italy Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  77. Spain Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  78. Spain Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  79. Spain Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  80. Asia Pacific Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  81. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  82. Asia Pacific Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  83. Asia Pacific Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  84. Asia Pacific Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  85. Asia Pacific Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  86. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  87. Asia Pacific Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  88. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  89. Asia Pacific Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  90. Asia Pacific Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  91. Asia Pacific Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  92. Asia Pacific Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  93. Asia Pacific Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  94. Asia Pacific Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  95. Asia Pacific Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  96. Asia Pacific Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  97. Asia Pacific Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  98. Asia Pacific Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  99. Japan Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  100. Japan Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  101. Japan Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  102. China Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  103. China Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  104. China Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  105. India Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  106. India Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  107. India Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  108. Australia Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  109. Australia Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  110. Australia Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  111. South Korea Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  112. South Korea Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  113. South Korea Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  114. Latin America Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  115. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  116. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  117. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  118. Latin America Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  119. Latin America Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  120. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  121. Latin America Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  122. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  123. Latin America Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  124. Latin America Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  125. Latin America Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  126. Latin America Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  127. Latin America Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  128. Latin America Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  129. Latin America Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  130. Latin America Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  131. Latin America Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  132. Latin America Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  133. Brazil Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  134. Brazil Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  135. Brazil Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  136. Argentina Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  137. Argentina Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  138. Argentina Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  139. Mexico Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  140. Mexico Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  141. Mexico Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  142. Rest of Latin America Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  143. Rest of Latin America Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  144. Rest of Latin America Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  145. Middle East and Africa Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  146. Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  147. Middle East and Africa Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  148. Middle East and Africa Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  149. Middle East and Africa Antiviral Market, By Region, From 2021 to 2026 (USD Billion)
  150. Middle East and Africa Psychiatry Market, By Region, From 2021 to 2026 (USD Billion)
  151. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  152. Middle East and Africa Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  153. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  154. Middle East and Africa Molecular Diagnostic Laboratories and Testing facilities Market, By Region, From 2021 to 2026 (USD Billion)
  155. Middle East and Africa Academic Institutes, clinical care and Research Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  156. Middle East and Africa Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Billion)
  157. Middle East and Africa Bio and health informatics companies Market, By Region, From 2021 to 2026 (USD Billion)
  158. Middle East and Africa Others (Service providers, partners, venture capitalists, etc.) Market, By Region, From 2021 to 2026 (USD Billion)
  159. Middle East and Africa Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  160. Middle East and Africa Companion Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  161. Middle East and Africa Biomarker identification Market, By Region, From 2021 to 2026 (USD Billion)
  162. Middle East and Africa Health Informatics Market, By Region, From 2021 to 2026 (USD Billion)
  163. Middle East and Africa Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  164. Middle East Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  165. Middle East Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  166. Middle East Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)
  167. Africa Personalized Medicine Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  168. Africa Personalized Medicine Market, By End User, From 2021 to 2026 (USD Billion)
  169. Africa Personalized Medicine Market, By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample